The distributions of the end-simulation adolescence-limited proportion when (a) <i>k</i> is increased or decreased by 50%, (b) <i>c</i> is increased or decreased by 50%, (c) <i>γ</i> is increased or decreased by 50%, and (d) Δ<i>e</i> is increased or decreased by 50%, compared against the benchmark distribution <i>F</i>(<b>p</b>₀) for the parameters shown in Table 1. حسب Jia Ning Leaw (752775)

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. حسب Bei Wang (116772)

NFκB-p50 knockdown decreases CD44 expression. حسب Shannon M. Smith (115335)

Prevalence and anatomic level of stenosis ≥ 50% in either limb. حسب O. Stivalet (6890189)

Affinity analysis results (with a confidence level above 50%). حسب Marta R. Jabłońska (8491404)

Cooperativity decreases with the expression level of CheA. حسب Stephan Eismann (835052)

IC₅₀ of indole alkaloid against alpha-glucosidase [26]. حسب Atikarn Janthongkaw (17020498)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. حسب Wendy Soria Sotillo (4408105)

EC50 and percentage decrease in intracellular <i>Listeria</i> viability for effective compounds. حسب Marie-Eve Charbonneau (5658799)

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. حسب Joseph Kamgno (81039)

"…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…"

Variable importance plot (mean decrease accuracy and mean decrease Gini). حسب Fernando Martinez-Taboada (8655132)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. حسب Rozita Mohd (7411322)

Surface tension versus time of the MHS solution (50 mM) and LNC dispersion containing 50 mM MHS as determined by drop tensiometry. حسب Celia R. A. Mouzouvi (4347937)

Definitions of the features selected [50]. حسب Yu Zhang (12946)

Topography of the relationship between the change in alpha power decrease and the change in M50 gating ratio. حسب Tzvetan Popov (315385)

"…B: Relationship between change in alpha power decrease (abscissa, negative values indicate improvement) and pre-to-post-training change in M50 gating ratio (ordinate, positive values indicate changes towards normal, that is, smaller gating ratio) by patient training group based on the ROI in 4A.…"

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. حسب Pascal Leclair (566971)

In-phase (A) and opposed phase (B) chemical shift MR images of a 51-year-old male demonstrate hepatic steatosis, consistent with areas of decreased signal intensity on an opposed-p... حسب Andrzej Cieszanowski (635105)

DMB treatment decreased neuronal apoptosis in cerebral ischemia. حسب Huinan Zhang (849524)

KOR-agonist (U50'488) and MOR-agonist (DAMGO) decrease symptoms in OVA-allergic mice. حسب Swantje C. Duncker (154707)

Revisiting the sealed heating method–heating cells in a low volume decreases nuclear Chk1. حسب Andrew J. Massey (239469)